Things appear to be looking up for Metlife Inc (MET)

Metlife Inc (NYSE: MET) is 2.07% higher on its value in year-to-date trading and has touched a low of $48.95 and a high of $73.12 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MET stock was last observed hovering at around $66.75 in the last trading session, with the day’s gains setting it 0.75%.

Currently trading at $67.50, the stock is -1.29% and 0.97% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.12 million and changing 1.12% at the moment leaves the stock 10.17% off its SMA200. MET registered -5.25% loss for a year compared to 6-month gain of 7.72%. The firm has a 50-day simple moving average (SMA 50) of $0.97.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


The stock witnessed a -2.60% loss in the last 1 month and extending the period to 3 months gives it a 13.73%, and is 2.35% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.76% over the week and 1.66% over the month.

Metlife Inc (MET) has around Feb 05 2024 employees, a market worth around $49.33B and $66.91B in sales. Current P/E ratio is 36.90 and Fwd P/E is 6.78. Profit margin for the company is 2.06%. Distance from 52-week low is 37.90% and -7.69% from its 52-week high. The company has generated returns on investments over the last 12 months (3.07%).

Metlife Inc quarterly earnings per share for the current quarter are estimated at $1.98 with sales reaching $17.7B over the same period.The EPS is expected to grow by 21.89% this year, but quarterly earnings will post 2.40% year-over-year. Quarterly sales are estimated to grow 4.90% in year-over-year returns.

Metlife Inc (MET) Top Institutional Holders

1,622 institutions hold shares in Metlife Inc (MET), with institutional investors hold 91.08% of the company’s shares. The shares outstanding are 730.80M, and float is at 612.31M with Short Float at 1.31%. Institutions hold 76.16% of the Float.

The top institutional shareholder in the company is Vanguard Group Inc with over 59.24 million shares valued at $3.35 billion. The investor’s holdings represent 7.88% of the MET Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 55.06 million shares valued at $3.11 billion to account for 7.32% of the shares outstanding. The other top investors are Dodge & Cox Inc which holds 54.15 million shares representing 7.20% and valued at over $3.06 billion, while Price (T.Rowe) Associates Inc holds 4.81% of the shares totaling 36.17 million with a market value of $2.04 billion.

Metlife Inc (MET) Insider Activity

A total of 25 insider transactions have happened at Metlife Inc (MET) in the last six months, with sales accounting for 0 and purchases happening 25 times. The most recent transaction is an insider sale by Khalaf Michel ,the company’sPresident & CEO. SEC filings show that Khalaf Michel sold 20,460 shares of the company’s common stock on Feb 05 at a price of $65.95 per share for a total of $1.35 million. Following the sale, the insider now owns 0.39 million shares.

Metlife Inc disclosed in a document filed with the SEC on Aug 09 that DEBEL MARLENE (EVP & Chief Risk Officer) sold a total of 9,391 shares of the company’s common stock. The trade occurred on Aug 09 and was made at $63.18 per share for $0.59 million. Following the transaction, the insider now directly holds 77638.0 shares of the MET stock.

Still, SEC filings show that on May 19, Johnson Jeh C. (Director) acquired 17 shares at an average price of $51.69 for $879.0. The insider now directly holds 2,526 shares of Metlife Inc (MET).

Metlife Inc (MET): Who are the competitors?

The company’s main competitors (and peers) include Autoliv Inc. (ALV) that is trading 21.87% up over the past 12 months. Cigna Group (CI) that is 12.18% higher over the same period.